NERV (Minerva Neurosciences) Insider Ownership: 1.11 % (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NERV Minerva Neurosciences Inc NERV
34 GF Score
Price $4.77
! 1 Warning Sign
View Full Analysis

What is Minerva Neurosciences Insider Ownership?

Minerva Neurosciences NERV -0.52% 34 Insider Ownership is 1.11 % as of Aug. 20, 2026. GuruFocus rates NERV with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Minerva Neurosciences's insider ownership is 1.11%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Minerva Neurosciences's Institutional Ownership is 84.19%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Minerva Neurosciences's Float Percentage Of Total Shares Outstanding is 95.53%.

Minerva Neurosciences Insider Ownership Historical Data

* Premium members only.

The historical data trend for Minerva Neurosciences's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Neurosciences Insider Ownership Chart

Minerva Neurosciences Historical Data

The historical data trend for Minerva Neurosciences can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 7.38 7.38 7.38 7.38 7.38 1.19 1.19 1.11 1.11 1.11
NERV
34GF Score
Minerva Neurosciences Inc NERV
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minerva Neurosciences Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 1.11 % mean?
Minerva Neurosciences (NERV) has a Insider Ownership of 1.11 % as of Aug. 20, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Minerva Neurosciences and its competitors.
Is Minerva Neurosciences' Insider Ownership too high?
Minerva Neurosciences' current Insider Ownership is 1.11 %. Overall, Minerva Neurosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Minerva Neurosciences' Insider Ownership compare to DTIL and VYGR?
Minerva Neurosciences' Insider Ownership of 1.11 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Minerva Neurosciences and its competitors. Minerva Neurosciences's current Insider Ownership is 1.11 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Neurosciences stock overvalued right now?
Minerva Neurosciences (NERV) has a current Insider Ownership of 1.11 %. The current Insider Ownership is 1.11 %. Minerva Neurosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Minerva Neurosciences (NERV), the current Insider Ownership is 1.11 % as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Neurosciences Business Description

Other Exchanges 4MNA:Germany
Address 1500 District Avenue, Burlington, MA, USA, 01803
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
34GF Score

Get the complete analysis for NERV

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.77
Price